NBIS Fundamentals.
1. Massive Growth – The stock’s up a jaw-dropping 138% in just 3 months!
2. YTD Beast Mode – Up 81.6% so far in 2025.
3. Momentum Heating Up – Gained 36.9% over the last month alone.
4. Super Low Debt – Debt-to-equity at just 0.06 — strong balance sheet!
5. Sitting on Cash – Over $6.42/share in cash with a killer 9.59 quick ratio.
6. Insider Confidence – 20.71% insider ownership, they believe in what they’re building.
7. EPS Looking Strong – Projected +41.91% EPS growth next year.
8. Big Money Watching – 33.26% institutional ownership, eyes are on this.
9. Revenue Turnaround – Insane 381% sales growth QoQ, the shift is real.
10 Wall Street Thumbs Up – Consensus Buy rating, score of 1.25.
NBIS Technicals:
1. High-Volume Breakout spotted on the weekly chart — clear signal buyers are stepping in.
2. Broke out of long-term downtrend resistance with authority. Consolidating on low volume.
3. Price holding above key EMAs — bullish structure intact.
4. Fib targets in sight with potential room to stretch toward $90-$120+.
5. Volume expansion confirms real accumulation happening.
Watching for continued strength as this beast tries to reclaim lost ground and ride that momentum wave. With fundamentals this solid and technicals aligning.
Trade active
Still experiencing a low volume pullback. waiting for volume to come in and buy pressure. seems in harmony still for higher prices. Supply Zone flipped to demand zone here.Note
Volume coming back in, 16% jump on the day. looking good for continuation, lots of red folder data starting tomorrow to get markets turning. fingers crossed.Note
July 14 - Nebius Group (NASDAQ:NBIS) shares jumped about 12% Monday morning after Goldman Sachs initiated coverage with a "Buy" rating and a $68 price target, which implies around 39% upside.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.